Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Kidney Medicine
|
October 7, 2022
The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKD
Ronald D Perrone, Ali Hariri, Pascal Minini, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 19, 2022
Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial
Ronald T Gansevoort, Ali Hariri, Pascal Minini, et al.
Journal of Alzheimer'S Disease : JAD
|
November 14, 2014
Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort
Jeffrey L Seeburger, Daniel J Holder, Marc Combrinck, et al.
Clinical Chemistry
|
March 9, 2013
Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale
Helen E White, John Hedges, Israel Bendit, et al.
Blood
|
August 4, 2010
Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)
Timothy P Hughes, Andreas Hochhaus, Susan Branford, et al.
Molecular Genetics and Metabolism
|
December 8, 2022
Venglustat, an orally administered glucosylceramide synthase inhibitor: Assessment over 3 years in adult males with classic Fabry disease in an open-label phase 2 study and its extension study
Patrick B Deegan, Ozlem Goker-Alpan, Tarekegn Geberhiwot, et al.
Human Molecular Genetics
|
July 5, 2020
Correction of cilia structure and function alleviates multi-organ pathology in Bardet-Biedl syndrome mice
Hervé Husson, Nikolay O Bukanov, Sarah Moreno, et al.
Journal of Lipid Research
|
January 30, 2026
Spatial Mapping of CoQ<sub>10</sub> Repletion by BPM31510 in a Genetic Mouse Model (Coq4<sup>F147C</sup>) of Coenzyme Q Deficiency
Eliana Barriocanal-Casado, Sylwia A Stopka, Alba Pesini, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 3, 2026
BPM31510 Increases the CoQ Pool in Chemically Induced CoQ-Deficient Cells, CoQ-Deficient Patient Fibroblasts, and in Metabolically Active Murine Tissues
Juan J Aristizabal-Henao, Sarah R Wessel, Sylwia A Stopka, et al.
Plos One
|
August 14, 2015
High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid
Ronald C Hendrickson, Anita Y H Lee, Qinghua Song, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Kidney Medicine
|
October 7, 2022
The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKD
Ronald D Perrone, Ali Hariri, Pascal Minini, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 19, 2022
Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial
Ronald T Gansevoort, Ali Hariri, Pascal Minini, et al.
Journal of Alzheimer'S Disease : JAD
|
November 14, 2014
Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort
Jeffrey L Seeburger, Daniel J Holder, Marc Combrinck, et al.
Clinical Chemistry
|
March 9, 2013
Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale
Helen E White, John Hedges, Israel Bendit, et al.
Blood
|
August 4, 2010
Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)
Timothy P Hughes, Andreas Hochhaus, Susan Branford, et al.
Molecular Genetics and Metabolism
|
December 8, 2022
Venglustat, an orally administered glucosylceramide synthase inhibitor: Assessment over 3 years in adult males with classic Fabry disease in an open-label phase 2 study and its extension study
Patrick B Deegan, Ozlem Goker-Alpan, Tarekegn Geberhiwot, et al.
Human Molecular Genetics
|
July 5, 2020
Correction of cilia structure and function alleviates multi-organ pathology in Bardet-Biedl syndrome mice
Hervé Husson, Nikolay O Bukanov, Sarah Moreno, et al.
Journal of Lipid Research
|
January 30, 2026
Spatial Mapping of CoQ<sub>10</sub> Repletion by BPM31510 in a Genetic Mouse Model (Coq4<sup>F147C</sup>) of Coenzyme Q Deficiency
Eliana Barriocanal-Casado, Sylwia A Stopka, Alba Pesini, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 3, 2026
BPM31510 Increases the CoQ Pool in Chemically Induced CoQ-Deficient Cells, CoQ-Deficient Patient Fibroblasts, and in Metabolically Active Murine Tissues
Juan J Aristizabal-Henao, Sarah R Wessel, Sylwia A Stopka, et al.
Plos One
|
August 14, 2015
High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid
Ronald C Hendrickson, Anita Y H Lee, Qinghua Song, et al.
Page
of 3